Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
Researchers have converted a bacterial toxin into a genome editing tool that, for the first time, can make precise changes to DNA in mitochondria, the cell’s power plants.
The Alzheimer’s epidemic no one is talking about. That’s where the work of Jennifer J. Manly, PhD, a professor of neuropsychology at Columbia University Irving Medical Center, comes in.